Apollo Hospitals Enterprise Limited · NSE:APOLLOHOSP

Apollo Hospitals Enterprise — Q1 FY25 Earnings Presentation

38 slides from Apollo Hospitals Enterprise's earnings presentation, Aug 13, 2024

  1. Slide 1: Regulation 30 disclosure cover letter

    II• APOLLO HOSPITALS ENTERPRISE LIMITED ~"'bllo ~OSPITALS CIN: L85110TN1979PLC008035 August 13, 2024 The Secretary, The Secretary, Bombay Stock Exchange Ltd (BSE) National Stock Exchange, Phiroze Jheejheebhoy Towers, Exchange Plaza, 5th Floor Dalal Street, Plot No.C/1, 'G' Block Mumbai - 400 001. Ba

  2. Slide 2: Apollo Hospitals Enterprise Limited Earnings Update Q1 FY25

    Apollo Hospitals Enterprise Limited • Earnings Update Q1 FY25

  3. Slide 3: Disclaimer

    Disclaimer The information contained in this presentation is provided by Apollo Hospitals Enterprise Limited (the “Company”) to you solely for your reference. This document is being given solely for your information and for your use and may not be retained by you and neither this presentation nor an

  4. Slide 4: Content

    Content Financial Performance Snapshot & Business Digital Health Segment wise Update & Pharmacy Distribution 4-8 (Apollo HealthCo) Consolidated Financials 10 Healthcare Services 12-21 Diagnostics & Retail Health (AHLL) 23-25 Digital Health & Pharmacy Distribution (Apollo HealthCo) 27-33 Annexure 35-

  5. Slide 5: Financial Performance Snapshot Q1FY25

    Financial Performance Snapshot Q1FY25 Growth Growth Growth (in ₹ Mio) Revenue YoY(%) EBITDA(Post Ind AS) YoY(%) Margin PAT YoY(%) 3,282 Healthcare Services 26,373 15% 6,217 15% 23.6% 24% Offline PD ^ 18,369 15% 1,388 11% 7.6% Apollo HealthCo Online PD^ & 2,452 19% ( 1,163 ) 24|7 Total HealthCo 20,82

  6. Slide 6: Largest Pan India Hospital Chain

    Largest Pan India Hospital Chain (•) Capacity Operational/ Hospitals Beds1 Census Beds Overall Total 73 10,121 9,363 Delhi: 5 Amritsar: 1 Noida: 1 Owned Hospitals 45 8,700 7,942 Bilaspur: 1 Kanpur: 1 Lucknow: 1 Indirapuram: 1 Managed Hospitals 6 790 790 Jaipur: 1 Day Surgery & 22 631 631 Cradle (AHL

  7. Slide 7: AHLL: Transforming Retail Health through access and convenience

    AHLL: Transforming Retail Health through access and convenience Apollo Health & Lifestyle Ltd Out-of-Hospital care • Outpatient Clinics • Diagnostics • Day Surgery centers • Single Specialty Facilities :- Dialysis, Sugar and Dental ~y Apollo Health and Lifestyle Ltd Organizing the unorganized • Path

  8. Slide 8: AHL | India's Largest Omni-channel Healthcare Platform

    AHL| India’s Largest Omni-channel Healthcare Platform Apollo HealthCo Ltd Apollo 24|7 Offline Pharmacy Distribution Key Differentiators • India’s largest Organized Pharmacy Platform with Unmatched Size • Built digital business scale in 1/3rd the • 35 Mn.+ Registered Users - 630,000 Daily time taken

  9. Slide 9: Clinical Updates and New Initiatives

    Clinical Updates and New Initiatives • Apollo is harnessing its internal network across tier 1 and tier 2 hospitals to offer patients access to cutting-edge technologies, such as Proton therapy in Chennai (over 100 procedures completed) and Zap-X in Delhi (more than 33 procedures performed). • Apoll

  10. Slide 10: Consolidated Financials

    • Consolidated Financials Consolidated Financials © 2024 Apollo Hospitals Enterprise Ltd, All Rights Reserved 9

  11. Slide 11: Consolidated Financials Q1FY25

    Consolidated Financials Q1FY25 (` mio) Digital Health & Healthcare Diagnostics & ` Mio Pharmacy Consol Overall Consolidated Revenue grew by 15% to Services Retail Health Distribution Total Revenues 26,373 3,661 20,821 50,856 ` 50,856 mio. EBITDA (Pre 24|7 Cost) 6,217 309 1,721 8,247 margin (%) 23.6%

  12. Slide 12: Healthcare Services Hospitals

    • Healthcare Services Hospitals © 2024 Apollo Hospitals Enterprise Ltd, All Rights Reserved 11

  13. Slide 13: Healthcare Services Financials Q1FY25

    Healthcare Services Financials Q1FY25 (` mio) ` Mio Q1FY25 Q1FY24 YoY Healthcare Services Revenue grew by 15% in Q1FY25 No of Hospitals 45 43 (Inpatient Volume grew by 11% ; Price & case mix of 4%) Operating beds 7,942 7,798 2% Occupancy 68% 62% Occupancy for Q1FY25 at 68% vs 62% in Q1FY24 IP Discha

  14. Slide 14: Inpatients Revenue Mix Q1FY25

    Inpatients Revenue Mix Q1FY25 Paed IPS Transplts Uro 3% PSU & Govt 3% Cardio 6% Nephro 4% 19% Self Pay 4% 10% Obs&Gynac 4% Gen Surg 4% 38% 8% Inpatient Inpatient Others Specialty Mix Payor Mix 17% Onco* 8% Internal Med 6% 47% Gastro 10% 10% Neuro Insurance & Pvt Ortho * Oncology includes Radiotherap

  15. Slide 15: Healthcare Services: Operational Snapshot

    Healthcare Services : Operational Snapshot Metros: Chennai, Hyderabad, Bangalore, Mumbai, Kolkata and Delhi Metro Non Metro Non Metros (includes Tier1 & Tier2 cities) Ahmedabad, Bhubaneshwar, Lucknow, Operating Indore, Guwahati, Madurai, Trichy, 4,535 3,407 Nellore,Vizag, Kakinada, Mysore, Nashik, B

  16. Slide 16: Tamil Nadu Region

    Tamil Nadu Region Metro:- Chennai ; Non Metro:- Madurai, Karur, Karaikudi, Trichy and Nellore Nellore Nellore Tamil Nadu Region Chennai Q1FY25 Q1FY24 YoY Operating Beds 2,051 2,088 -1.8% Bed Occupancy Rate (%) 64% 58% Inpatient volume 37,519 35,246 6.4% Trichy Outpatient volume(1) 150,055 139,143 7.

  17. Slide 17: AP, Telangana Region

    AP, Telangana Region Metro:- Hyderabad; Non Metro:- Karimnagar, Vizag and Kakinada Vishakhapatnam AP, Telangana Region Q1FY25 Q1FY24 YoY Operating Beds 1,240 1,270 -2.4% Bed Occupancy Rate (%) 63% 54% Inpatient volume 19,729 18,529 6.5% Kakinada (1) Karimnagar Outpatient volume 67,687 48,383 39.9% H

  18. Slide 18: Karnataka Region

    Karnataka Region Metro:- Bangalore; Non Metro:- Mysore Karnataka Region Q1FY25 Q1FY24 YoY Operating Beds 746 756 -1.3% Bed Occupancy Rate (%) 76% 61% Inpatient volume 17,295 15,093 14.6% Outpatient volume(1) 71,876 47,663 50.8% Inpatient ALOS (days) 2.99 2.80 6.7% Inpatient revenue (` mio) 2,643 2,2

  19. Slide 19: Eastern Region

    Eastern Region Metro:- Kolkata; Non Metro:- Guwahati, Bhubaneshwar, Bilaspur and Rourkela Eastern Region Q1FY25 Q1FY24 YoY Operating Beds 1,827 1,771 3.2% Guwahati Bed Occupancy Rate (%) 75% 69% Inpatient volume 32,934 29,577 11.4% (1) Outpatient volume 109,461 99,822 9.7% Kolkata Inpatient ALOS (da

  20. Slide 20: Western Region

    Western Region Metro:- Navi Mumbai; Non Metro:- Nashik and Ahmedabad Western Region Q1FY25 Q1FY24 YoY Ahmedabad Operating Beds 861 802 7.4% Bed Occupancy Rate (%) 55% 50% Inpatient volume 12,543 10,154 23.5% Outpatient volume(1) 40,321 54,624 -26.2% Nashik Inpatient ALOS (days) 3.42 3.56 -3.9% Mumba

  21. Slide 21: Northern Region

    Northern Region Metro:- Delhi; Non Metro:- Lucknow and Indore Northern Region Delhi Q1FY25 Q1FY24 YoY Operating Beds 1,217 1,111 9.5% Lucknow Bed Occupancy Rate (%) 72% 74% Inpatient volume 26,842 23,924 12.2% (1) Outpatient volume 82,350 72,891 13.0% Inpatient ALOS (days) 2.97 3.11 -4.5% Inpatient

  22. Slide 22: Healthcare Services: Expansion Plan

    Healthcare Services: Expansion Plan Balance Total Census Location Nature Project Cost Remarks Beds Beds (in Crs) Expected commisioning : FY26 Commissioning planned for April 2025 with 200 beds Phase 1, along with structural readiness for additional Royal Mudhol Pune Hospital Asset Acquisition 425 35

  23. Slide 23: Diagnostics & Retail Health Apollo Health & Lifestyle Ltd

    • Diagnostics & Retail Health Apollo Health & Lifestyle Ltd © 2024 Apollo Hospitals Enterprise Ltd, All Rights Reserved 22

  24. Slide 24: Executive Summary

    Executive Summary Primary Care Diagnostics Specialty Care ~.A 'ollo Dialysis Clinics !p~~-~QJ 10nls_ ~llo """"'= """"" ,- Suga; Clinics Apollo DIAGNOSTICS ® '.A Apollo Soectra IHOSPITALS 9 Specialists in Surgery ~lo Cradle &Children's Hospital ltolloFertility  Core revenues of Primary Care grew by

  25. Slide 25: AHLL Financials Q1FY25

    AHLL Financials Q1FY25 (` mio) Corporate / Primary Care Diagnostics Specialty Care AHLL Intra Group Revenue 964 1,164 1,725 -192 3,661 AHLL Revenues grew by 15% YoY in Q1’ EBITDA 180 110 184 -165 309 FY25; primarily attributed to maturing Q1FY25 margin (%) 18.6% 9.4% 10.7% 8.4% network EBIT 110 73 1

  26. Slide 26: Diagnostics: Key Parameters

    Diagnostics : Key Parameters Gross Revenue (INR Mn)1 EBITDA (INR Mn)2 Operational footprint 1,239 12% (as of June 30, 2024) 3 14% 1,169 1,164 5 1 ~330+ 1,122 10% 9% ~330+ 4 7% Cities Cities presence 1,075 1,236 168 presence 16 149 1,165 1,163 1,118 75 112 110 1,059 Q1 FY24 Q2 FY24 Q3 FY24 Q4 FY24 Q1

  27. Slide 27: Digital Health & Pharmacy Distribution Apollo HealthCo

    Digital Health & Pharmacy • Distribution Apollo HealthCo © 2024 Apollo Hospitals Enterprise Ltd, All Rights Reserved 26

  28. Slide 28: India's Largest Omni-Channel Healthcare Platform

    India’s Largest Omni-Channel Healthcare Platform Apollo 247 Digital Platform Apollo Pharmacy Platform 6,074 Stores ~16.1% Omni Private ~35 Mn+ Registrations n hi Manish - Added 46 label / generics Chandigarh: 4 mix Closed 2 - Q1’ FY 25 ,r; Book Apollo Doctor Appoinlmc,nl , >) Himachal Pradesh: 5 Utt

  29. Slide 29: Apollo HealthCo Financials Q1FY25

    Apollo HealthCo Financials Q1FY25 (` mio) Online Offline Healthco (Q1’ FY25 vs Q1’ FY24); Pharmacy Total Health ` Mio Pharmacy Distribution & Co Distribution o 15% growth in revenue in Q1’ FY25 vs Q1’ FY24 Apollo 247 Total Revenues 18,369 2,452 20,821 o EBITDA positive in Q1’FY25 (Rs. 225 Mn) vs los

  30. Slide 30: Apollo HealthCo: Transaction Summary

    Apollo HealthCo : Transaction Summary • Apollo Healthco Limited (“AHL”) to raise equity capital of INR 2,475 Cr (USD 300 Mn) from Advent International (“Advent”)1, one of the largest global private equity investors with an AUM of over USD 94 Bn Overview • Proposes integration of Keimed Private Limit

  31. Slide 31: Synergetic Benefit of the Keimed Merger

    Synergetic Benefit of the Keimed Merger Becoming India’s Leading Healthcare Provider 1 Leading Pharma End-to-end, Patient retention Distributor seamless, omnichannel User satisfaction + business model of pharmacy Cross selling Growing Omni distribution with a Apollo Channel Platform fast-growing dig

  32. Slide 32: Proposed Transaction Structure and Steps (1/2)

    Proposed Transaction Structure and Steps (1/2) Pre-Transaction Post Advent Tranche 1 Investment Post Advent Tranche 2 Investment (As of date) (T) (T+12 Months) AHEL ESOP AHEL Advent ESOP AHEL Advent ESOP 95% 5*% 83.1% 12.5%1 4.4% 79.0% 16.9% 4.1% 2% 11.2% AHL AHL Keimed AHL Keimed Tranche 1 Tranche

  33. Slide 33: Proposed Transaction Structure and Steps (2/2)

    Proposed Transaction Structure and Steps (2/2) Launch of Merger Process Post Merger (T+15 Months) (T+30 Months) Keimed AHEL Promoters Keimed 61.5% AHEL 79.0% Shareholders Other minority Advent ESOP FHPL partners 59.2%** 25.7%# Min Max 16.9% 4.1% 16.1% 11.2% Advent ESOP 11.2%* 12.1%+ 3.0% AHL Keimed

  34. Slide 34: Combined Financials Metrics Snapshot Q1FY25

    (•) Combined Financials Metrix| Snapshot Q1FY25 (` mio) Combined Offline Pharma Online Pharma Combined Distribution Total Healthco Keimed Combined FY24 Distribution+247 Q1’FY25 Revenue 137,701 18,369 2,452 20,821 29,973 37,379 EBITDA,Pre 9,614 1,327 315 1,642 938 2,580 INDAS EBITDA % 7.0% 7.2% 12.8%

  35. Slide 35: Annexure

    • Annexure © 2024 Apollo Hospitals Enterprise Ltd, All Rights Reserved 34

  36. Slide 36: Basis of Consolidation

    Basis of Consolidation AHEL AHEL Standalone Hospitals (100% Ownership) Location Subsidiaries Location Description Ownership Chennai Main Chennai Material Subs ACI - Chennai Chennai Apollo Health Co limited India Digital Omni-Channel Healthcare services Platform 100.00% Tondiarpet - Chennai Chennai A

  37. Slide 37: IND AS 116: Impact on P&L and Balance Sheet Q1FY25

    IND AS - 116 : Impact on P&L and Balance Sheet –Q1FY25 AHEL Standalone (post IND AS 116) AHEL Consolidated (post IND AS 116) Balance sheet Profit & Loss Balance sheet Profit & Loss Right of use Asset 12,893 Revenue Right of use Asset 20,057 Revenue as of Other expenses 241 as of Other expenses 607 3

  38. Slide 38: Thank you !!

    Thank you !! 37

Apollo Hospitals Enterprise — Q1 FY25 Earnings Presentation on 6ix